Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India-Reference-Cited by-同舟云学术

Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India

Published:2023-04 Issue: Volume:11 Page:100154
ISSN:2772-3682
Container-title:The Lancet Regional Health - Southeast Asia
language:en
Short-container-title:The Lancet Regional Health - Southeast Asia

Author:

Sajgure Atul^ORCID,Kulkarni Ajit,Joshi Atul,Sajgure Vasanti^ORCID,Pathak Vaishali,Melinkeri Rashida^ORCID,Pathak Shilpa,Agrawal Sumit,Naik Manoj,Rajurkar Milind,Sajgure Ameya^ORCID,Date Girish

Publisher

Elsevier BV

Reference33 articles.

1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Date accessed: Jan 12, 2023.

2. Estimating mortality from COVID-19. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1. Date accessed: April 26, 2022.

3. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis;Macedo;Ann Epidemiol,2021

4. The cytokine storm and COVID-19;Hu;J Med Virol,2021

5. The variant gambit: COVID-19's next move;Plante;Cell Host Microbe,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03

2. Design and characterization of BSA-mycophenolic acid nanocomplexes: Antiviral activity exploration;International Journal of Biological Macromolecules;2024-04

3. Immunosuppressants against acute kidney injury: what to prefer or to avoid?;Immunopharmacology and Immunotoxicology;2024-03-18

4. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China;Lupus;2024-02-05

5. Safety and efficacy of mycophenolate in COVID-19;The Lancet Regional Health - Southeast Asia;2023-11